Results 51 to 60 of about 82,762 (302)

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

The essence of specialized knowledge used in the investigation of criminal offenses against justice

open access: yesАрхів кримінології та судових наук
Given the importance of special knowledge in solving tactical tasks of investigation and tasks of criminal proceedings, the purpose of the article is to define the concept, essence and typical forms of special knowledge used in the investigation of ...
Volodymyr Grytsenko
doaj   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

Separate discussed questions of standartization of authorities of a head of the pre-trial investigation body

open access: yes, 2019
Статтю присвячено дослідженню сучасного стану нормативно-правового регулювання повноважень керівника органу досудового розслідування. Наголошено, що ефективне забезпечення виконання органами досудового розслідування завдань кримінального провадження ...
Вікторія Абламська   +5 more
core   +1 more source

Criminal Proceedings in the Absence of the Suspect or Accused (in absentia): Legislative Transformations and Current Regulation

open access: yesLaw and Safety
The article examines the transformation and current standardisation of criminal proceedings in the absence of a suspect or defendant (in absentia) in the context of the development of Ukrainian criminal procedural law.
T. H. Fomina
doaj   +1 more source

Special procedural measures and the protection of human rights<br> General report

open access: yesUtrecht Law Review, 2009
The aim of the general report is to conduct a comparative analysis of the national reports in order to trace transformation processes in domestic criminal justice systems, in particular criminal process, as special procedural measures are introduced to ...
John A.E. Vervaele
doaj   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Procedural forms of using special knowledge during the investigation of military crimes

open access: yes, 2022
У статті підкреслено, що використання спеціальних знань під час розслідування військових злочинів є одним із способів оптимізації процесу досудового розслідування.
Бершов, Г. Є., Bershov, H. Ye.
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy